Visual field changes in methotrexate therapy: Case report and review of the literature

Journal Medical Libanais

Volumn 54, Issue 3, 2006, Pages 164-167

  Sbeity, Zaher H ^a   Baydoun, Lamis ^a   Schmidt, Stephan ^a   Loeffler, Karin U ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; METHOTREXATE; ANTIRHEUMATIC AGENT;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; LUMBAR PUNCTURE; NEUROLOGIC EXAMINATION; OPTIC NERVE DISEASE; PERIMETRY; PSORIATIC ARTHRITIS; SCOTOMA; VISUAL FIELD; VISUAL FIELD DEFECT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MIDDLE AGED; REVIEW;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; OPTIC NERVE DISEASES; VISUAL FIELDS;

EID: 33847282051     PISSN: 00239852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Wollina U, Ständer K, Barta U. Toxicity of Methotrexate treatment in psoriasis and psoriatic arthritis - Short- and long-term toxicity in 104 patients. Clin Rheumatol 2001 ; 20 : 406-10.
2. Ponjavic V, Granse L, Stigmar EB, Andreasson S. Reduced full-field electroretinogram (ERG) in a patient treated with Methotrexate. Acta Ophthalomol Scand 2004 ; 82 (19) : 96-9.
3. Balachandran C, McCluskey P, Champion D, Halmagyi M. Methotrexate-induced optic neuropathy. Clin Exp Ophthalmol 2002 ; 30 ; 440-1.
4. Clare G, Colley S, Kennett R, Elston JS. Reversible optic neuropathy associated with low-dose Methotrexate therapy. J Neuroophthalmol 2005 Jun ; 25 (2) : 109-12.